"Executive Summary:  Global viral vectors-based gene therapy for non-human primates market size was valued at USD 1.26 billion in 2024 and is projected to reach USD 3.99 billion by 2032, with a CAGR of 15.40% during the forecast period of 2025 to 2032  The global Viral Vectors-Based Gene Therapy for Non-Human Primates Market is poised for robust expansion in the coming...